GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®, Victoza®) have rapidly become some of the most widely prescribed medications for weight loss and metabolic health. By reducing appetite, improving insulin signaling, lowering blood sugar, and slowing stomach emptying, these medications can be powerful tools for individuals struggling with obesity or type 2 diabetes.
However, an important issue is often overlooked: supplement use. Many people taking GLP-1 medications also use dietary supplements in an effort to enhance weight loss or support metabolic health. Because most supplements are widely marketed as “safe,” consumers often assume they can combine them with medications. Unfortunately, that is not always the case.
Certain supplements, for example, can amplify the metabolic effects of GLP-1 medications or worsen their gastrointestinal side effects, potentially leading to dizziness, low blood sugar, nausea, bloating, or digestive discomfort. Understanding these hidden risks can help patients use GLP-1 therapies more safely and effectively.
Why Supplement Interactions Matter. GLP-1 medications work by influencing several key physiological processes. They stimulate insulin secretion, reduce glucagon levels, slow gastric emptying, and promote feelings of fullness. These mechanisms help regulate blood sugar and reduce caloric intake. When supplements that also lower blood sugar or affect gastrointestinal motility are added to the mix, the combined effects may become excessive.
For example, patients may experience symptoms of hypoglycemia such as weakness, shakiness, lightheadedness, or fatigue. Others may develop worsening gastrointestinal symptoms, including severe bloating, constipation, or nausea. While these effects may not occur in everyone, they highlight the importance of being cautious when combining supplements with prescription medications.
Supplements That Require Caution
- Berberine
Berberine has become increasingly popular as a natural metabolic supplement. It works through several pathways, including activation of AMP-activated protein kinase (AMPK), which improves insulin sensitivity and lowers blood glucose levels.
Because berberine already has glucose-lowering effects similar to some diabetes medications, combining it with GLP-1 drugs may amplify those effects. This could increase the risk of hypoglycemia, particularly in individuals who are also taking other glucose-lowering medications. Berberine may also slow intestinal motility, which can worsen nausea and bloating, two of the most common side effects reported with GLP-1 therapies.
- Blood Sugar–Lowering Botanicals
Herbal supplements such as bitter melon, gymnema sylvestre, and banaba are often marketed as natural treatments for blood sugar control. While these botanicals may offer metabolic benefits, they can further reduce glucose levels when taken alongside GLP-1 medications.
For some individuals, this combination may lead to symptoms such as dizziness, weakness, or lightheadedness due to excessive blood sugar reduction.
- High-Dose Chromium
Chromium is frequently promoted as a supplement to support insulin sensitivity and weight loss. While the small amounts found in multivitamins are typically safe, high-dose chromium supplements may intensify glucose-lowering effects when combined with GLP-1 medications.
- Large Amounts of Fiber Supplements
Fiber plays an important role in digestive and metabolic health. However, high doses of fiber supplements such as psyllium, glucomannan, or konjac may worsen gastrointestinal symptoms in people using GLP-1 medications. Because GLP-1 drugs already slow gastric emptying, excessive fiber supplementation may increase bloating, constipation, or abdominal discomfort.
- Alpha-Lipoic Acid (High Dose)
Alpha-lipoic acid is commonly used to support metabolic health and nerve function. In higher doses, it may improve insulin sensitivity and lower blood sugar levels. When combined with GLP-1 medications, these effects may contribute to unwanted drops in glucose levels.
- Thermogenic “Fat Burner” Supplements
Weight-loss supplements often contain stimulant compounds such as high doses of caffeine or herbal thermogenic ingredients. These products may aggravate nausea, increase heart rate, and worsen dizziness—particularly in individuals whose appetite and caloric intake are already significantly reduced by GLP-1 medications.
A Simpler, Safer Approach is best:
For most people using GLP-1 medications, a simple supplement strategy is best. Basic nutritional support such as a multivitamin, vitamin D, omega-3 fatty acids, adequate protein intake, and balanced electrolytes is usually well tolerated and may help maintain overall health during weight loss. Patients should always discuss supplement use with their healthcare provider to ensure that combinations are safe and appropriate for their specific medical conditions.
The Take Home Message:
GLP-1 medications are powerful tools for improving metabolic health and supporting weight management. But because these medications significantly influence blood sugar regulation and digestive function, combining them with certain supplements can create unexpected risks. Remember that “natural” does not always mean harmless. Thoughtful guidance from healthcare professionals can help ensure that GLP-1 therapy remains both safe and effective.
About the Author:
Edison de Mello, MD, PhD, the author of Bloated: How to Eat Without Pain is an integrative physician, researcher, and educator specializing in functional and metabolic medicine. He is the founder and medical director of the Akasha Center for Integrative Medicine in Santa Monica, California.
Dr. de Mello’s signature philosophy is simple but powerful: we meet our patients before we meet their diseases. His work focuses on identifying the root causes of illness by integrating conventional medicine with nutrition, lifestyle medicine, and mind–body approaches. His mission at the Akasha Center iis reflected in the guiding principle: “A Better Way to Get Better.”
References
- Nauck MA, et al.
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
Journal of Clinical Endocrinology & Metabolism. 2025;110(1):1–15. (OUP Academic) - Maurer AH.
Glucagon-Like Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly.
Journal of Nuclear Medicine Technology. 2024;52(1):3-7. (tech.snmjournals.org) - Rayner CK, Horowitz M.
Gastrointestinal Effects of GLP-1 Receptor Agonists: Mechanisms and Clinical Implications.
The Lancet Gastroenterology & Hepatology. 2024. (ScienceDirect) - Reese R.
Is Berberine “Nature’s GLP-1”?
Pharmacy Times. 2025. (Pharmacy Times) - Expert guidance on supplement interactions with GLP-1 medications (including berberine, chromium, and alpha-lipoic acid).
EatingWell / Registered Dietitian Expert Review. 2024. (EatingWell)
Mechanisms of berberine in glucose metabolism via AMPK activation and insulin sensitivity pathways.
Review summaries of metabolic studies and meta-analyses. (Fella Health)
